Clinical Trial Update: Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients

View source ↗

Summary

A clinical trial evaluating cellular immune responses in the liver of patients with chronic hepatitis C has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Diseases
• Viral Diseases

Snippet

Sponsor: University of Ulm | Conditions: Hepatitis C, Chronic, Liver Diseases | Status: WITHDRAWN